West Pharmaceutical Services

Recent news

• J.P. Morgan Maintains Visteon(VC.US) With Buy Rating, Raises Target Price to $170
  Market Newswire · 2026/8/10
• Citi Initiates West Pharmaceutical Services(WST.US) With Buy Rating, Announces Target Price $412
  Market Newswire · 2026/8/3
• Rating change
  A Quick Look at Today's Ratings for West Pharmaceutical Services(WST.US), With a Forecast Between $400 to $410
  Market Newswire · 2026/7/24
• Rating change
  Evercore Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Raises Target Price to $425
  Market Newswire · 2026/7/27
• Rating change
  Barclays Maintains Visteon(VC.US) With Buy Rating, Maintains Target Price $145
  Market Newswire · 2026/7/27
• Company notice
  4: Visteon | 4: Statement of changes in beneficial ownership of securities-Director Bergman Naomi M.
  SEC · 2026/6/10
• Company notice
  Visteon | 4: Statement of changes in beneficial ownership of securities-Director Bergman Naomi M.
  SEC · 2025/6/10
• Company notice
  IGBCR: Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - WAH SEONG (MALAYA) TRADING CO. SDN BHD ("WST")
  Bursa Malaysia · 2025/11/19
• Company notice
  Visteon | 4: Statement of changes in beneficial ownership of securities-Director Bergman Naomi M.
  SEC · 2024/6/11
• Rating change
  RBC Capital Maintains Visteon(VC.US) With Buy Rating, Cuts Target Price to $129
  Market Newswire · 2026/7/24
• Rating change
  Goldman Sachs Maintains Visteon(VC.US) With Buy Rating, Cuts Target Price to $126
  Market Newswire · 2026/7/27
• Rating change
  BofA Securities Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Announces Target Price $410
  Market Newswire · 2026/7/24
• Rating change
  Analysts Offer Insights on Consumer Cyclical Companies: Reynolds Consumer Products (REYN), Visteon (VC) and Amer Sports, Inc. (AS)
  TipRanks · 2026/7/27
• Morgan Stanley Maintains West Pharmaceutical Services(WST.US) With Hold Rating, Maintains Target Price $365
  Market Newswire · 2026/9/15
• Rating change
  Wolfe Research Downgrades Visteon(VC.US) to Hold Rating
  Market Newswire · 2026/7/28
• Morgan Stanley Upgrades West Pharmaceutical Services(WST.US) to Buy Rating, Raises Target Price to $400
  Market Newswire · 2026/9/22
• Company notice
  Visteon | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(7.57%),Wellington Group Holdings LLP(7.57%), etc.
  SEC · 2024/11/8
• Rating change
  UBS Maintains Visteon(VC.US) With Buy Rating, Maintains Target Price $130
  Market Newswire · 2026/7/24
• J.P. Morgan Maintains Visteon(VC.US) With Buy Rating, Cuts Target Price to $145
  Market Newswire · 2026/9/15

Headlines are aggregated automatically and are not independently verified or edited by our team.